Annual Information Update
ANNUAL INFORMATION UPDATE FOR GLAXOSMITHKLINE PLC
FOR THE 12 MONTHS UP TO 25 MARCH 2011
In accordance with the requirements of Prospectus Rules PR 5.2.1R please find below an Annual Information Update for GlaxoSmithKline plc ("The Company"). The information referred to in this update was up to date at the time the information was published, but some information may now be out of date.
To avoid an unnecessarily lengthy document the following are summaries of the information and documents published or made available to the public, by the Company throughout the twelve months ended 25 March 2011.
1. Announcements made via RNS, a Regulatory Information Service.
The announcements listed below were published on the London Stock Exchange via RNS, a Regulatory Information Service and can be obtained from their website www.londonstockexchange.com or the Company's website www.gsk.com.
|
24/03/2011 |
Transaction in Own Shares |
|
23/03/2011 |
Transaction in Own Shares |
|
22/03/2011 |
Transaction in Own Shares |
|
21/03/2011 |
Transaction in Own Shares |
|
21/03/2011 |
Director/PDMR Shareholding |
|
21/03/2011 |
Notice of Meeting for AGM 2011 |
|
21/03/2011 |
Transaction in Own Shares - Amendment |
|
18/03/2011 |
Transaction in Own Shares |
|
17/03/2011 |
Transaction in Own Shares |
|
16/03/2011 |
Transaction in Own Shares |
|
15/03/2011 |
Transaction in Own Shares |
|
14/03/2011 |
Director/PDMR Shareholding |
|
11/03/2011 |
Notification pursuant to Listing Rule 9.6.13 |
|
11/03/2011 |
Transaction in Own Shares |
|
10/03/2011 |
Transaction in Own Shares |
|
10/03/2011 |
Director/PDMR Shareholding |
|
09/03/2011 |
Transaction in Own Shares |
|
08/03/2011 |
Transaction in Own Shares |
|
07/03/2011 |
Director/PDMR Shareholding |
|
07/03/2011 |
Director/PDMR Shareholding |
|
07/03/2011 |
GSK files its Annual Report 2010 on Form 20-F |
|
04/03/2011 |
Transaction in Own Shares |
|
04/03/2011 |
Directorate Change |
|
03/03/2011 |
Transaction in Own Shares |
|
02/03/2011 |
Transaction in Own Shares |
|
02/03/2011 |
Annual Report and Accounts |
|
01/03/2011 |
Director/PDMR Shareholding |
|
01/03/2011 |
Director/PDMR Shareholding |
|
01/03/2011 |
Total Voting Rights |
|
25/02/2011 |
Director/PDMR Shareholding |
|
25/02/2011 |
Director/PDMR Shareholding |
|
25/02/2011 |
Director/PDMR Shareholding |
|
25/02/2011 |
Director/PDMR Shareholding |
|
25/02/2011 |
Transaction in Own Shares |
|
24/02/2011 |
Transaction in Own Shares |
|
23/02/2011 |
Transaction in Own Shares |
|
23/02/2011 |
Director/PDMR Shareholding |
|
23/02/2011 |
Director/PDMR Shareholding |
|
22/02/2011 |
Transaction in Own Shares |
|
22/02/2011 |
Director/PDMR Shareholding |
|
22/02/2011 |
Director/PDMR Shareholding |
|
22/02/2011 |
Director/PDMR Shareholding |
|
21/02/2011 |
Director/PDMR Shareholding |
|
21/02/2011 |
Director/PDMR Shareholding |
|
21/02/2011 |
Notifiable share interest in Theravance, Inc. |
|
21/02/2011 |
Office of Fair Trade Merger Update |
|
18/02/2011 |
Transaction in Own Shares |
|
17/02/2011 |
Transaction in Own Shares |
|
16/02/2011 |
Transaction in Own Shares |
|
16/02/2011 |
Director/PDMR Shareholding |
|
15/02/2011 |
Transaction in Own Shares |
|
14/02/2011 |
Director/PDMR Shareholding |
|
14/02/2011 |
Director/PDMR Shareholding |
|
14/02/2011 |
Office of Fair Trade Merger Update |
|
11/02/2011 |
Transaction in Own Shares |
|
10/02/2011 |
Transaction in Own Shares |
|
10/02/2011 |
Director/PDMR Shareholding |
|
09/02/2011 |
Transaction in Own Shares |
|
08/02/2011 |
Transaction in Own Shares |
|
07/02/2011 |
Transaction in Own Shares |
|
07/02/2011 |
Director/PDMR Shareholding |
|
04/02/2011 |
Transaction in Own Shares |
|
04/02/2011 |
Director/PDMR Shareholding |
|
04/02/2011 |
Director/PDMR Shareholding |
|
03/02/2011 |
Final Results |
|
02/02/2011 |
GSK sells entire shareholding in Quest Diagnostics |
|
01/02/2011 |
Director/PDMR Shareholding |
|
01/02/2011 |
Total Voting Rights |
|
27/01/2011 |
Director/PDMR Shareholding |
|
24/01/2011 |
Director/PDMR Shareholding |
|
17/01/2011 |
Director/PDMR Shareholding |
|
17/01/2011 |
GSK announces Q4 2010 legal charge |
|
13/01/2011 |
Director/PDMR Shareholding |
|
13/01/2011 |
Director/PDMR Shareholding |
|
13/01/2011 |
Director/PDMR Shareholding |
|
13/01/2011 |
Director/PDMR Shareholding |
|
12/01/2011 |
Director/PDMR Shareholding |
|
12/01/2011 |
Director/PDMR Shareholding |
|
10/01/2011 |
Director/PDMR Shareholding |
|
10/01/2011 |
Director/PDMR Shareholding |
|
10/01/2011 |
Director/PDMR Shareholding |
|
10/01/2011 |
Director/PDMR Shareholding |
|
07/01/2011 |
Director/PDMR Shareholding - Replacement |
|
07/01/2011 |
Director/PDMR Shareholding |
|
05/01/2011 |
Director/PDMR Shareholding |
|
04/01/2011 |
Total Voting Rights |
|
04/01/2011 |
Director/PDMR Shareholding |
|
21/12/2010 |
Proximagen Group PLC: Acquisition of Programmes from GSK |
|
20/12/2010 |
Director/PDMR Shareholding |
|
16/12/2010 |
Office of Fair Trade Merger Update |
|
13/12/2010 |
GSK to acquire Maxinutrition |
|
10/12/2010 |
Director/PDMR Shareholding |
|
07/12/2010 |
GSK to acquire Nanjing MeiRui Pharmaceuticals |
|
01/12/2010 |
Total Voting Rights |
|
29/11/2010 |
GSK to increase its shareholding in Theravance |
|
12/11/2010 |
Blocklisting Interim Review |
|
10/11/2010 |
Director/PDMR Shareholding |
|
08/11/2010 |
Director/PDMR Shareholding |
|
03/11/2010 |
Director/PDMR Shareholding |
|
01/11/2010 |
Total Voting Rights |
|
21/10/2010 |
3rd Quarter Results |
|
14/10/2010 |
Director/PDMR Shareholding |
|
13/10/2010 |
Director/PDMR Shareholding |
|
13/10/2010 |
Director/PDMR Shareholding |
|
13/10/2010 |
Director/PDMR Shareholding |
|
13/10/2010 |
Director/PDMR Shareholding |
|
12/10/2010 |
Director/PDMR Shareholding |
|
12/10/2010 |
Director/PDMR Shareholding |
|
12/10/2010 |
Director/PDMR Shareholding |
|
11/10/2010 |
Director/PDMR Shareholding |
|
08/10/2010 |
Director/PDMR Shareholding |
|
08/10/2010 |
Director/PDMR Shareholding |
|
04/10/2010 |
GSK takes stake in Convergence Pharmaceuticals |
|
01/10/2010 |
Director/PDMR Shareholding |
|
01/10/2010 |
Total Voting Rights |
|
23/09/2010 |
GSK regulatory update on Avandia |
|
10/09/2010 |
Director/PDMR Shareholding |
|
10/09/2010 |
Notification pursuant to Listing Rule 9.6.13 |
|
10/09/2010 |
GSK historical quarterly turnover by product |
|
08/09/2010 |
Directorate Change |
|
01/09/2010 |
Total Voting Rights |
|
25/08/2010 |
Director/PDMR Shareholding |
|
18/08/2010 |
Holding(s) in Company |
|
11/08/2010 |
Notification of Transactions - Director/PDMR Shareholding |
|
10/08/2010 |
Director/PDMR Shareholding |
|
09/08/2010 |
Director/PDMR Shareholding |
|
05/08/2010 |
Director/PDMR Shareholding |
|
05/08/2010 |
Director/PDMR Shareholding |
|
05/08/2010 |
Director/PDMR Shareholding |
|
04/08/2010 |
Holding(s) in Company |
|
03/08/2010 |
Holding(s) in Company |
|
02/08/2010 |
Director/PDMR Shareholding |
|
02/08/2010 |
Total Voting Rights |
|
29/07/2010 |
Publication of Prospectus |
|
29/07/2010 |
Publication of Registration Document |
|
27/07/2010 |
Director/PDMR Shareholding |
|
23/07/2010 |
Director/PDMR Shareholding - Replacement |
|
21/07/2010 |
Half Yearly Report |
|
15/07/2010 |
GSK Legal Update |
|
15/07/2010 |
Response to FDA Advisory Committees' Avandia vote |
|
14/07/2010 |
Director/PDMR Shareholding |
|
13/07/2010 |
Director/PDMR Shareholding |
|
13/07/2010 |
Director/PDMR Shareholding |
|
13/07/2010 |
Director/PDMR Shareholding |
|
13/07/2010 |
Director/PDMR Shareholding |
|
13/07/2010 |
Director/PDMR Shareholding |
|
12/07/2010 |
Director/PDMR Shareholding |
|
12/07/2010 |
Director/PDMR Shareholding |
|
12/07/2010 |
Director/PDMR Shareholding |
|
07/07/2010 |
Director/PDMR Shareholding |
|
02/07/2010 |
Change of Announcement Date |
|
01/07/2010 |
Total Voting Rights |
|
01/07/2010 |
Director/PDMR Shareholding |
|
30/06/2010 |
Futura Medical PLCGlaxoSmithKline PLC - TPR100 Agreement with GSK |
|
10/06/2010 |
Director/PDMR Shareholding |
|
10/06/2010 |
GSK drives Latin America growth strategy |
|
01/06/2010 |
Total Voting Rights |
|
13/05/2010 |
Director/PDMR Shareholding |
|
11/05/2010 |
GSK New Strategic Alliance in South Korea |
|
10/05/2010 |
Blocklisting Interim Review |
|
07/05/2010 |
Director/PDMR Shareholding |
|
07/05/2010 |
Director/PDMR Shareholding |
|
06/05/2010 |
AGM Statement |
|
04/05/2010 |
Director/PDMR Shareholding |
|
04/05/2010 |
Total Voting Rights |
|
28/04/2010 |
1st Quarter Results |
|
21/04/2010 |
Director/PDMR Shareholding |
|
19/04/2010 |
Director/PDMR Shareholding |
|
16/04/2010 |
Director/PDMR Shareholding |
|
15/04/2010 |
Director/PDMR Shareholding |
|
14/04/2010 |
Director/PDMR Shareholding |
|
14/04/2010 |
Director/PDMR Shareholding |
|
14/04/2010 |
Director/PDMR Shareholding |
|
14/04/2010 |
Director/PDMR Shareholding |
|
13/04/2010 |
Director/PDMR Shareholding |
|
13/04/2010 |
Director/PDMR Shareholding |
|
12/04/2010 |
Director/PDMR Shareholding |
|
07/04/2010 |
Director/PDMR Shareholding |
|
07/04/2010 |
Director/PDMR Shareholding |
|
01/04/2010 |
Total Voting Rights |
|
01/04/2010 |
Director/PDMR Shareholding |
|
30/03/2010 |
Vernalis PLC GlaxoSmithKline PLC - Holding(s) in Company |
|
29/03/2010 |
Notifiable share interest in JCR Pharmaceuticals |
|
26/03/2010 |
Change to Board Committee |
|
26/03/2010 |
Notifiable share interest in JCR Pharmaceuticals |
|
25/03/2010 |
Annual Information Update |
2. Documents filed at Companies House
All documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated, and can be obtained from Companies House via their website www.companieshouse.gov.uk
|
Date |
Document Type |
Description of Document Filed |
|
23/03/2011 |
SH03 |
Return of Purchase of Own Shares |
|
17/03/2011 |
SH03 |
Return of Purchase of Own Shares |
|
14/03/2011 |
SH01 |
Statement of Capital |
|
03/03/2011 |
SH01 |
Statement of Capital |
|
14/02/2011 |
SH01 |
Statement of Capital |
|
02/02/2011 |
SH01 |
Statement of Capital |
|
25/01/2011 |
SH01 |
Statement of Capital |
|
19/01/2011 |
AP01 |
Appointment of Director |
|
17/01/2011 |
SH01 |
Statement of Capital |
|
17/01/2011 |
AP03 |
Appointment of Secretary |
|
14/01/2011 |
TM02 |
Termination of Secretary's Appointment |
|
07/01/2011 |
SH01 |
Statement of Capital |
|
26/11/2010 |
SH01 |
Statement of Capital |
|
26/11/2010 |
SH01 |
Statement of Capital |
|
16/11/2010 |
SH01 |
Statement of Capital |
|
08/11/2010 |
CH01 |
Director's Change of Particulars |
|
03/11/2010 |
CH01 |
Director's Change of Particulars |
|
03/11/2010 |
CH01 |
Director's Change of Particulars |
|
01/11/2010 |
SH01 |
Statement of Capital |
|
01/11/2010 |
AR01 |
Annual Return |
|
13/10/2010 |
SH01 |
Statement of Capital |
|
01/10/2010 |
SH01 |
Statement of Capital |
|
14/09/2010 |
SH01 |
Statement of Capital |
|
02/09/2010 |
SH01 |
Statement of Capital |
|
13/08/2010 |
SH01 |
Statement of Capital |
|
02/08/2010 |
SH01 |
Statement of Capital |
|
16/07/2010 |
SH01 |
Statement of Capital |
|
08/07/2010 |
SH01 |
Statement of Capital |
|
09/06/2010 |
SH01 |
Statement of Capital |
|
04/06/2010 |
SH01 |
Statement of Capital |
|
20/05/2010 |
RES08 |
Authority to purchase shares out of Capital |
|
20/05/2010 |
RES11 |
Dis-application of pre-emption Rights |
|
20/05/2010 |
RES01 |
Alteration to Memorandum and Articles |
|
14/05/2010 |
SH01 |
Statement of Capital |
|
07/05/2010 |
AA |
Accounts |
|
07/05/2010 |
SH01 |
Statement of Capital |
|
15/04/2010 |
SH01 |
Statement of Capital |
|
13/04/2010 |
SH01 |
Statement of Capital |
3. Documents filed with the Securities and Exchange Commission ("SEC")
The Company submitted filings to the SEC in compliance with its obligations under national laws and rules dealing with the regulation of securities, issuers of securities and securities markets by virtue of having American Depository Shares admitted to trading on the New York Stock Exchange. Full details of these filings can be found on the SEC's website at www.sec.gov.
4. Documents sent to shareholders
The following documents were published and sent to shareholders. They are available on the Company's website.
|
Date of Publication |
Document |
|
02/03/2011 |
Annual Report and Accounts |
|
21/03/2011 |
Notice of Annual General Meeting |
A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Company Secretary at the Company's registered office:
Victoria Whyte
Company Secretary
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
Tel: 020 8047 5000
This information is provided by RNS